Region: Global
Category: Pharmaceuticals

Global Pharmaceuticals

(23,237 reports matching your criteria)
  • Nucleating and Clarifying Agents

    ... reach US$5.5 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Packaging Application, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach ... Read More

  • Online Home Rental Services

    ... reach US$65.8 Billion by 2030, growing at a CAGR of 12.9% over the analysis period 2023-2030. Flats, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$36.3 ... Read More

  • Clinical Rollators

    ... at a CAGR of 5.0% over the analysis period 2023-2030. 4-Wheeler Rollators, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$262.0 Million by the end of ... Read More

  • In-Vitro Colorectal Cancer Screening Tests

    ... is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record ... Read More

  • Hazmat Suits

    ... at a CAGR of 4.7% over the analysis period 2023-2030. Infection Control & Bio-Hazard Application, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$5.6 Billion by ... Read More

  • High Pressure Pumps

    ... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Dynamic Pumps, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.0 Billion by ... Read More

  • Human Papillomavirus (HPV) Testing

    ... reach US$1.8 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR ... Read More

  • Needle-Free IV Connectors

    ... by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Positive Fluid Displacement Connectors, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$997.5 ... Read More

  • Nursing Breast Pads

    ... by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Reusable Nursing Breast Pads, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$220.4 ... Read More

  • Anesthesia Gas Blenders

    ... by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Tube Flow Meter Technology, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$467.1 ... Read More

  • Compound Management

    ... at a CAGR of 16.9% over the analysis period 2023-2030. Compound Management Instruments, one of the segments analyzed in the report, is expected to record a 17.2% CAGR and reach US$752.6 Million by the end ... Read More

  • Automotive Electronics Conformal Coatings

    ... reach US$1.4 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Acrylic Application, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach ... Read More

  • Hybrid and Electric Vehicle Fuses

    ... is expected to reach US$10.3 Billion by 2030, growing at a CAGR of 24.4% over the analysis period 2023-2030. Hybrid Electric Vehicles (HEVs) Application, one of the segments analyzed in the report, is expected to ... Read More

  • Global Ranibizumab Drugs and Biosimilars Market Growth 2024-2030

    ... disease.Biosimilars of ranibizumab are biologic products that are highly similar to the original reference drug(ranibizumab)in terms of structure,efficacy,safety,and quality.These biosimilars aim to provide more affordable treatment options while maintaining therapeutic equivalence to the original biologic ... Read More

  • Digital Diabetes Management

    ... at a CAGR of 18.6% over the analysis period 2023-2030. Digital Diabetes Management Devices, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$46.7 Billion by the ... Read More

  • Insulin Storage Devices

    ... at a CAGR of 7.3% over the analysis period 2023-2030. Battery Operated Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$996.0 Million by the end ... Read More

  • Walnut

    ... 2.8% over the analysis period 2023-2030. Black Walnuts, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$570.1 Million by the end of the analysis period. Growth ... Read More

  • Soft Tissue Allografts

    ... at a CAGR of 4.9% over the analysis period 2023-2030. Orthopedic Application, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of ... Read More

  • Women's Health Rehabilitation Products

    ... 2030, growing at a CAGR of 1.2% over the analysis period 2023-2030. Orthopedic Rehabilitation Products, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$731.9 Million by ... Read More

  • Manual Filling Equipment

    ... at a CAGR of 6.6% over the analysis period 2023-2030. Food & Beverages End-Use, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.1 Billion by the ... Read More

  • Global Pyrrolidine Market Report, History and Forecast 2019-2030

    ... of 3.18% during 2024-2030. North American market for Pyrrolidine was valued at $ 10.22 million in 2023 and will reach $ 12.02 million by 2030, at a CAGR of 2.15% during the forecast period of ... Read More

  • Glutathione - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

    ... of US$ 135.57 million by 2030 with a CAGR of 6.84% during the forecast period 2024-2030. North American market for Glutathione was valued at $ 39.52 million in 2023 and will reach $ 62.70 million ... Read More

  • Intraoperative Radiation Therapy

    ... at a CAGR of 5.8% over the analysis period 2023-2030. Systems / Accelerators, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$22.9 Million by the end ... Read More

  • Opioid Use Disorder (OUD) Market Size, Share, and Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, Sublingual, and Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

    ... Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034 Opioid Use Disorder (OUD) Market Size, Share, and Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, ... Read More

  • Cold Pressed Juices

    ... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Mixed Fruit & Vegetable Juices, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach ... Read More

Cookie Settings